Extract of Cynara, Pharmaceutical composition containing them； and their use for the treatment of hyperglycemia, Hypercholesterolemia, hypertension and fatty liver.
The present invention relates to the preparation of Cynara scolymus leaf extracts, which are useful for the prevention and treatment of dyslipidaemia, in particular to increase HDL cholesterol in patients at cardiovascular risk. Said extracts are useful to normalize the lipid and carbohydrate balances and significantly increase the value of HDL cholesterol by favorably changing the LDL/HDL ratio, especially in post-infarction patients with drug-induced dyslipidaemia.un extracto de las hojas de las variedades correspondientes a la especie Cynara que tiene un contenido de ácido cafeoilquínico de 30-45% p/p, un contenido de flavonoide de 8-16% p/p y un contenido de cinaropicrina de 10-18% p/p. Usos y composición que la comprende.
